Avalo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.99	15.86	134.55	7.42	13.17	54.59
Short-Term Investments	57.01	82.48	-	-	-	-
Cash & Short-Term Investments	81.99	98.34	134.55	7.42	13.17	54.59
Cash Growth	-34.43%	-26.91%	1714.51%	-43.71%	-75.87%	188.52%
Accounts Receivable	-	-	-	-	-	1.06
Other Receivables	-	-	-	0.14	1.92	3.74
Total Trade Receivables	-	-	-	0.14	1.92	4.8
Inventory	-	-	-	-	0.02	0.04
Other Current Assets	6.83	6.95	4.34	0.84	1.31	2.42
Total Current Assets	88.83	105.29	138.89	8.4	16.42	61.85
Net Property, Plant & Equipment	0.38	0.46	1.21	1.97	2.41	2.7
Other Intangible Assets	-	-	-	-	-	0.04
Goodwill	10.5	10.5	10.5	10.5	14.41	14.41
Other Long-Term Assets	0.18	0.21	0.13	0.13	0.13	1.23
Total Assets	99.89	116.46	150.73	20.99	33.37	80.21
Accounts Payable	0.36	0.14	0.28	0.45	2.88	3.37
Accrued Expenses	11.24	12.8	6.32	4.17	13.21	16.52
Short-Term Debt	-	-	-	-	5.93	-
Unearned Revenue	-	-	-	-	0.09	-
Other Current Liabilities	-	-	0.36	-	-	-
Total Current Liabilities	11.6	12.94	6.96	4.62	22.11	19.89
Long-Term Debt	-	-	-	-	13.49	32.83
Other Long-Term Liabilities	19.97	20.47	10.74	9.07	8.68	4.41
Total Long-Term Liabilities	19.97	20.47	10.74	9.07	22.17	37.24
Total Liabilities	31.57	33.41	17.7	13.69	44.28	57.13
Common Stock	0.03	0.02	0.01	0	0	0.01
Additional Paid-in Capital	536.45	531.49	503.29	342.44	292.91	285.24
Accumulated Other Comprehensive Income	-0.01	0.07	-	-	-	-
Retained Earnings	-468.15	-448.52	-370.26	-335.13	-303.82	-262.17
Shareholders' Equity	68.32	83.05	133.03	7.3	-10.92	23.08
Total Liabilities & Equity	99.89	116.46	150.73	20.99	33.37	80.21
Total Debt	-	0	0	0	19.42	32.83
Net Cash (Debt)	81.99	98.34	134.55	7.42	-6.24	21.75
Net Cash Growth	-16.62%	-26.91%	1714.51%	-	-	14.97%
Net Cash Per Share	0.02	7.34	17.95	26.70	-22.48	615.62
Book Value	68.32	83.05	133.03	7.3	-10.92	23.08
Book Value Per Share	0.02	6.20	17.75	26.30	-39.30	653.26
Tangible Book Value	57.82	72.55	122.53	-3.2	-25.32	8.64
Tangible Book Value Per Share	0.02	5.41	16.35	-11.51	-91.18	244.39

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q